Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 8Myelodysplastic Syndromes 7Myeloproliferative Disorders 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Acute 6Leukemia 6Congenital Abnormalities 6Anemia, Refractory 5Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Multiple Myeloma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Anemia, Aplastic 2Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Recurrence 1Primary Myelofibrosis 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

eltrombopag 14romiplostim 7avatrombopag 7Platelet Transfusion 6Cytarabine 6Radiotherapy 4Filgrastim 4Etoposide 4Carboplatin 4oprelvekin 3Tranexamic Acid 3Peripheral Blood Stem Cell Transplantation 3Daunorubicin 3Cyclophosphamide 3Busulfan 3hetrombopag 2fludarabine phosphate 2Tretinoin 2Thrombopoietin 2Lenalidomide 2Interleukin-11 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Doxorubicin 2Cyclosporine 2Amplified Fragment Length Polymorphism Analysis 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2sodium thiosulfate 1siltuximab 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × sargramostim × Classical hematology × Clear all
NCT00012376 2013-01-09

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer

National Cancer Institute (NCI)

Phase 1 Completed
35 enrolled
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, Blast Crisis, Hemoglobinuria, Paroxysmal, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡